Our top 10 pharma client’s patient share in the market had plateaued.
This was due, in part, to the global shift towards virtual client engagement – plus an influx of competitors – that combined to make the specialist prescription medicine sales environment more and more difficult.
As an organization, we brought value to the client by connecting specialists from Inizio Advisory (STEM) and Inizio Engage (Cormis) to blend an array of complimentary services to address the issue at hand.
Through the use of commercial performance benchmarking, our team found that the coaching methods used for the client’s sales representatives needed a revamp. Their method had fallen behind the level expected in the industry, and this was having a detrimental long-term impact.
We then brought in a revised program of capability development & training to help nurture and improve the coaching skills employed throughout the company. Our team also supplied further coaching to help their sales reps navigate the post-pandemic landscape more effectively.
Thanks to our support of our connected capabilities, the client saw a marked improvement in their overall culture.
Following our overhaul of the client’s methodology, when the business was assessed in greater depth, the evolution was clear:
This all had a notable impact on patient share. The client had gained a 3% increase since the start of our partnership, with their products achieving greater visibility as a result.
Jump to a slide with the slide dots.
Our client was new to the complement system space and was preparing to launch an oral, first-in-class medication in a rare blood disease.
Read moreA top 10 pharma company wanted dermatologists to own the conversation on PsA, and become confident in diagnosing the disease.
Read moreA top 10 global pharma company wanted to challenge the status quo when it came to planning and prioritizing congresses.
Read more